{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:15:29Z","timestamp":1789038929572,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.crad.2023.11.010","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T17:44:48Z","timestamp":1701279888000},"page":"94-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The vigabatrin-associated brain abnormalities on MRI and their differential diagnosis"],"prefix":"10.1016","volume":"79","author":[{"given":"D.G.","family":"Corr\u00eaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Telles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. de A.L.","family":"Freddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2023.11.010_bib1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/WNO.0000000000000609","article-title":"Vigabatrin: lessons learned from the United States experience","volume":"38","author":"Foroozan","year":"2018","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.crad.2023.11.010_bib2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1469-8749.2001.tb00172.x","article-title":"Vigabatrin","volume":"43","author":"Lewis","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.crad.2023.11.010_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00702-009-0186-0","article-title":"Elevated endogenous GABA concentration attenuates glutamate-glutamine cycling between neurons and astroglia","volume":"116","author":"Yang","year":"2009","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.crad.2023.11.010_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3940(03)00072-7","article-title":"Effect of vigabatrin on glutamate dehydrogenase in the hippocampus of seizure prone gerbils","volume":"340","author":"Kang","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.crad.2023.11.010_bib5","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1345\/aph.18376","article-title":"Vigabatrin: a novel therapy for seizure disorders","volume":"33","author":"Gidal","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.crad.2023.11.010_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200124050-00005","article-title":"Visual field defects and other ophthalmological disturbances associated with vigabatrin","volume":"24","author":"Spence","year":"2001","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.crad.2023.11.010_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejpn.2012.10.009","article-title":"Are vigabatrin induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms?","volume":"17","author":"Dill","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.crad.2023.11.010_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5603\/PJNNS.a2021.0063","article-title":"Vigabatrin\u2014new data on indications and safety in paediatric epilepsy","volume":"55","author":"Golec","year":"2021","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.crad.2023.11.010_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nurt.2006.11.008","article-title":"Vigabatrin","volume":"4","author":"Wheless","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.crad.2023.11.010_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40261-017-0595-z","article-title":"West syndrome: a review and guide for paediatricians","volume":"38","author":"D'Alonzo","year":"2018","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.crad.2023.11.010_bib11","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1007\/s10072-020-04600-5","article-title":"West syndrome: a comprehensive review","volume":"41","author":"Pavone","year":"2020","journal-title":"Neurol Sci"},{"key":"10.1016\/j.crad.2023.11.010_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.seizure.2010.11.018","article-title":"Infantile spams without hypsarrhythmia: a study of 16 cases","volume":"20","author":"Caraballo","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.crad.2023.11.010_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/08830738030180041201","article-title":"Magnetic resonance imaging findings in infantile spasms: etiologic and pathophysiologic aspects","volume":"18","author":"Saltik","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.crad.2023.11.010_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s11910-012-0334-z","article-title":"Latest American and European updates on infantile spasms","volume":"13","author":"Lux","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.crad.2023.11.010_bib15","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1517\/14656560903451690","article-title":"Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval","volume":"10","author":"Tolman","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.crad.2023.11.010_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/019262338701500203","article-title":"A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-hooded rats","volume":"15","author":"Butler","year":"1987","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.crad.2023.11.010_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.clinimag.2015.07.016","article-title":"Brain MRI findings with vigabatrin therapy: case report and literature review","volume":"40","author":"Hussain","year":"2016","journal-title":"Clin Imaging"},{"key":"10.1016\/j.crad.2023.11.010_bib18","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1528-1167.2010.02564.x","article-title":"Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms","volume":"51","author":"Dracopoulos","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.crad.2023.11.010_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1528-1167.2008.01896.x","article-title":"Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy","volume":"50","author":"Wheless","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.crad.2023.11.010_bib20","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1111\/epi.14032","article-title":"White matter spongiosis with vigabatrin therapy for infantile spasms","volume":"59","author":"Pearl","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.crad.2023.11.010_bib21","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/epi.13712","article-title":"Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent","volume":"58","author":"Hussain","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.crad.2023.11.010_bib22","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/j.1528-1167.2007.01195.x","article-title":"Different neuronal networks are associated with spikes and slow activity in hypsarrhythmia","volume":"48","author":"Siniatchkin","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.crad.2023.11.010_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.410310212","article-title":"Infantile spasms: II. Lenticular nuclei and brain stem activation on positron emission tomography","volume":"31","author":"Chugani","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.crad.2023.11.010_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/jamaneurol.2013.1858","article-title":"Reversible vigabatrin-induced life-threatening encephalopathy","volume":"71","author":"Hern\u00e1ndez Vega","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.crad.2023.11.010_bib25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1528-1167.2008.01728.x","article-title":"Cerebral MRI abnormalities associated with vigabatrin therapy","volume":"50","author":"Pearl","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.crad.2023.11.010_bib26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s12098-015-2020-z","article-title":"Reversible MRI changes in an infant with epileptic spasms on low dose vigabatrin","volume":"83","author":"Jain","year":"2016","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.crad.2023.11.010_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1590\/0004-282x20170192","article-title":"Globus pallidus restricted diffusion associated with vigabatrin therapy","volume":"76","author":"Trindade","year":"2018","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.crad.2023.11.010_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1469-8749.2007.02017.x","article-title":"Transient magnetic resonance diffusion abnormalities in West syndrome: the radiological expression of non-convulsive status epilepticus?","volume":"50","author":"Desguerre","year":"2008","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.crad.2023.11.010_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/0883073808324219","article-title":"Transient brain magnetic resonance imaging hyperintensity in basal ganglia and brain stem of epileptic infants treated with vigabatrin","volume":"24","author":"Milh","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1016\/j.crad.2023.11.010_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.semperi.2009.10.003","article-title":"Magnetic resonance spectroscopy imaging of the newborn brain\u2014a technical review","volume":"34","author":"Xu","year":"2010","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.crad.2023.11.010_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.crad.2008.07.002","article-title":"Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications","volume":"64","author":"Soares","year":"2009","journal-title":"Clin Radiol"},{"key":"10.1016\/j.crad.2023.11.010_bib32","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00247-011-2191-3","article-title":"Medication neurotoxicity in children","volume":"41","author":"Iyer","year":"2011","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.crad.2023.11.010_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0920-1211(94)90033-7","article-title":"Vigabatrin-induced lesions in the rat brain demonstrated by quantitative magnetic resonance imaging","volume":"18","author":"Jackson","year":"1994","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.crad.2023.11.010_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/syn.20038","article-title":"Development of vigabatrin-induced lesions in the rat brain studied by magnetic resonance imaging, histology, and immunocytochemistry","volume":"53","author":"Preece","year":"2004","journal-title":"Synapse"},{"issue":"Suppl. 1","key":"10.1016\/j.crad.2023.11.010_bib35","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1007\/s00247-010-1838-9","article-title":"Vigabatrin-associated diffusion MRI abnormalities in tuberous sclerosis","volume":"40","author":"Thapa","year":"2010","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.crad.2023.11.010_bib36","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3174\/ajnr.A7437","article-title":"DWI hyperintensity in the fornix fimbria on MRI in children","volume":"43","author":"Rootman","year":"2022","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.crad.2023.11.010_bib37","first-page":"125","article-title":"Focal lesion in the splenium of the corpus callosum in epileptic patients: anti-epileptic drug toxicity?","volume":"20","author":"Kim","year":"1999","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.crad.2023.11.010_bib38","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/j.1528-1167.2005.00256.x","article-title":"Reversible cytotoxic edema in the splenium of the corpus callosum related to anti-epileptic treatment: report of two cases and literature review","volume":"46","author":"Prilipko","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.crad.2023.11.010_bib39","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1148\/rg.2017160085","article-title":"Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations","volume":"37","author":"Starkey","year":"2017","journal-title":"RadioGraphics"},{"key":"10.1016\/j.crad.2023.11.010_bib40","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/dmcn.12188","article-title":"An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms","volume":"55","author":"Fong","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.crad.2023.11.010_bib41","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/1971400915598082","article-title":"Vigabatrin-induced MRI changes associated with extrapyramidal symptoms in a child with infantile spasms","volume":"28","author":"Schonstedt","year":"2015","journal-title":"Neuroradiol J"},{"key":"10.1016\/j.crad.2023.11.010_bib42","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1111\/epi.16663","article-title":"Fulminant vigabatrin toxicity during combination therapy with adrenocorticotropic hormone for infantile spasms: Three cases and review of the literature","volume":"61","author":"Bhalla","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.crad.2023.11.010_bib43","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1528-1157.2000.tb00219.x","article-title":"Acute encephalopathy associated with vigabatrin in a six-month-old girl","volume":"41","author":"Haas-Lude","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.crad.2023.11.010_bib44","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/WNL.44.10.1944","article-title":"MRI monitoring of vigabatrin-induced intramyelinic edema in dogs","volume":"44","author":"Weiss","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.crad.2023.11.010_bib45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/1059-1311(92)90019-W","article-title":"MRI findings in epileptic patients on vigabatrin for more than 5 years","volume":"1","author":"Cocito","year":"1992","journal-title":"Seizure"},{"key":"10.1016\/j.crad.2023.11.010_bib46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0920-1211(90)90092-A","article-title":"Neuropathology of a human hippocampus following long-term treatment with vigabatrin: lack of microvacuoles","volume":"6","author":"Agosti","year":"1990","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.crad.2023.11.010_bib47","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1177\/0883073809348796","article-title":"Pathological evidence of vacuolar myelinopathy in a child following vigabatrin administration","volume":"24","author":"Horton","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1016\/j.crad.2023.11.010_bib48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3174\/ajnr.A2224","article-title":"Abnormal axial diffusivity in the deep gray nuclei and dorsal brain stem in infantile spasm treated with vigabatrin","volume":"32","author":"Simao","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.crad.2023.11.010_bib49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1528-1157.2000.tb00134.x","article-title":"The potential for vigabatrin-induced intramyelinic edema in humans","volume":"41","author":"Cohen","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.crad.2023.11.010_bib50","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1590\/S0004-282X2011000700034","article-title":"Treatment of West syndrome with vigabatrin: reversible MRI signal changes","volume":"69","author":"Carvalho Neto","year":"2011","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.crad.2023.11.010_bib51","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1535-7511.2009.01316.x","article-title":"Vigabatrin's complicated journey\u2014to be or not to be?","volume":"9","author":"Ben-Menachem","year":"2009","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.crad.2023.11.010_bib53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1148\/rg.282075066","article-title":"Hypoxic\u2013ischemic brain injury: imaging findings from birth to adulthood","volume":"28","author":"Huang","year":"2008","journal-title":"RadioGraphics"},{"key":"10.1016\/j.crad.2023.11.010_bib54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.crad.2023.02.011","article-title":"An approach to reporting paediatric leukoencephalopathy and leukodystrophies","volume":"78","author":"Davies","year":"2023","journal-title":"Clin Radiol"},{"key":"10.1016\/j.crad.2023.11.010_bib55","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00062-021-01030-4","article-title":"Neuromitochondrial disorders: genomic basis and an algorithmic approach to imaging diagnostics","volume":"31","author":"Senthilvelan","year":"2021","journal-title":"Clin Neuroradiol"},{"key":"10.1016\/j.crad.2023.11.010_bib56","doi-asserted-by":"crossref","first-page":"e2316","DOI":"10.1212\/WNL.0000000000010367","article-title":"Teaching NeuroImages: symmetrical abnormalities of the globi pallidi in succinic semialdehyde dehydrogenase deficiency","volume":"95","author":"Esposito","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.crad.2023.11.010_bib57","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1212\/WNL.0b013e3181cc0b7b","article-title":"Teaching NeuroImages: MRI in methylmalonic acidemia","volume":"74","author":"Bindu","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.crad.2023.11.010_bib58","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/197140091102400403","article-title":"The encephalopathic child","volume":"24","author":"Abeyakoon","year":"2011","journal-title":"Neuroradiol J"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926023005330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926023005330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:49:18Z","timestamp":1757868558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926023005330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0009926023005330"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2023.11.010","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The vigabatrin-associated brain abnormalities on MRI and their differential diagnosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2023.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}]}}